Navigation Links
Decision Resources' Market Access Tracker Now Covers the Middle East and Africa
Date:6/18/2013

BURLINGTON, Mass., June 18, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, announces that its Market Access Tracker service now includes coverage of the Middle East and Africa. Market Access Tracker analyzes the challenges and opportunities to gaining and maintaining favorable market access terms in four international regions comprising 24 countries. The countries covered by Market Access Tracker make up the world's largest mature pharmaceutical markets, which have dominated global prescription drug sales for decades, as well as key emerging markets, which will be the main drivers of growth in the future.

(Logo:  http://photos.prnewswire.com/prnh/20130103/MM36784LOGO )

In the Middle East and Africa, pharmaceutical markets vary enormously in terms of economic growth, stability and potential. According to South Africa: Market Access Tracker, South Africa is viewed as the gateway to sub-Saharan Africa, which is growing faster than the regional economies of Central and Eastern Europe, Latin America and the European Union. And although Turkey is characterized by a hostile drug pricing and cost containment landscape, Turkey: Market Access Tracker finds that the geopolitical opportunities provided from operating in Turkey and the country's goal to become a major regional player offers significant advantages to drug developers. 

"Not
'/>"/>

SOURCE Decision Resources
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
2. Poor Health Decisions Cost Billions; New Report Identifies Unhealthy Behavior as Top Concern of Benefit Providers
3. Watson to Present at the Sanford C. Bernstein 28th Annual Strategic Decisions Conference
4. Pharmaceutical Commercial Leaders Seek Global Benchmarks for More Informed Decision-Making
5. Cardinal Health Specialty Solutions Launches PathWare™ Decision Support Transaction Solutions
6. Thomson Reuters Speeds Regulatory Decision Making with New Pharmaceutical Intelligence Solution
7. ICON Medical Imaging Selects AG Mednet to Give Clinical Trial Sponsors Zero-Delay Efficiency and Faster Decision-Making Results
8. Response to U.S. Supreme Courts Healthcare Decision by Michael Zamagias, Chairman, TeleTracking Technologies
9. ACR Chooses NDSC to Deliver ACR Select, a Comprehensive EHR-Enabled Medical Imaging Clinical Decision Support Platform
10. inVentiv Medical Management Forms Partnership with Vital Decisions
11. Savient Pharmaceuticals Receives Favorable Decision In Tang Capital Litigation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... Future Prospects for Companies in Antihistamines, Corticosteroids, ... - new study showing you trends, partnerships, and ... allergic rhinitis drugs heading? What are the commercial prospects ... you potential revenues and other trends to 2025, discussing ... report provides 273 tables, charts, and graphs. Discover the ...
(Date:9/4/2015)... , Sep. 04, 2015 ... of the "Investigation Report on China,s Sodium Ibandronate Market, ... and used in the clinic under the trade name of ... Austria in 1996, sodium ibandronate was approved by ... treatment of osteoporosis under the trade name of Boniva. However, ...
(Date:9/4/2015)... September 4, 2015 Hutchison ... that Hutchison MediPharma Limited ("HMP"), its drug R&D ... second proof-of-concept ("POC") trial of fruquintinib in patients ... in China .  The top-line ... meeting the primary efficacy endpoint of progression free ...
Breaking Medicine Technology:Allergic Rhinitis Drugs Market Forecast 2015-2025 2Allergic Rhinitis Drugs Market Forecast 2015-2025 3Allergic Rhinitis Drugs Market Forecast 2015-2025 4Allergic Rhinitis Drugs Market Forecast 2015-2025 5Allergic Rhinitis Drugs Market Forecast 2015-2025 6Allergic Rhinitis Drugs Market Forecast 2015-2025 7Investigation Report on China's Sodium Ibandronate Market 2010-2019 2Second Proof-of-concept Trial of Fruquintinib Achieves its Primary Endpoint 2Second Proof-of-concept Trial of Fruquintinib Achieves its Primary Endpoint 3
... Late Stage Clinical Therapeutic Cancer... -- TUEBINGEN, Germany, September 21, 2010 ... ... ... ,; var first_result; // Results are keyed by longUrl, so we need to grab the first one. ...
... Inc., today announced that it reported positive preclinical ... Association for the Study of Diabetes (EASD).  CCX140, ... the chemokine receptor CCR2, improved metabolic function while ... in an animal model, and was well tolerated ...
Cached Medicine Technology:immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 2immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 3immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 4immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 5immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 6immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 7immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 8immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 9immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 10ChemoCentryx Reports Positive Results and Completion of Phase I Clinical Studies of Novel CCR2 Antagonist, CCX140, at the European Association for the Study of Diabetes (EASD) 2ChemoCentryx Reports Positive Results and Completion of Phase I Clinical Studies of Novel CCR2 Antagonist, CCX140, at the European Association for the Study of Diabetes (EASD) 3ChemoCentryx Reports Positive Results and Completion of Phase I Clinical Studies of Novel CCR2 Antagonist, CCX140, at the European Association for the Study of Diabetes (EASD) 4
(Date:9/4/2015)... ... September 04, 2015 , ... A Union County charitable ... Core Compassion Project is a non-profit organization dedicated to offering Pilates scholarships to ... cancer treatments and recover their mobility, strength, and range of motion following breast ...
(Date:9/4/2015)... Maui HI (PRWEB) , ... September 04, 2015 , ... ... the best ways for couples to explore, revitalize and strengthen their ‘couple-ness,’” says ... and his team at Four Seasons Resort Maui, the island’s only Forbes Five Star ...
(Date:9/4/2015)... , ... September 04, 2015 , ... The USC Eye ... ranked number 9 nationwide by Doximity. Faculty, residents and staff are honored to ... pride in the quality of our ophthalmology residency program. Our faculty places a high ...
(Date:9/4/2015)... ... September 04, 2015 , ... Lalonde Gordon ran a ... followed up with victory in the men’s 400 meters final, with an impressive 44.89 ... Field Championships in San Jose, Costa Rica in August 2015. The 44.64 time is ...
(Date:9/4/2015)... ... September 04, 2015 , ... FiltersFast.com, the ... offer that cannot be passed up. FiltersFast.com, will ship all orders over ... water filtration product replacements. Take advantage of this promotion now through September 8, ...
Breaking Medicine News(10 mins):Health News:Girl’s Night Out to Benefit Core Compassion Project, Located at the Beautiful, Morning Glory Farm 2Health News:Couples Season at Four Seasons Resort Maui Begins This Week With Best Hotel Rates of the Year through November 2Health News:Couples Season at Four Seasons Resort Maui Begins This Week With Best Hotel Rates of the Year through November 3Health News:USC Ophthalmology Residency Program Ranked in Top 10 by Doximity 2Health News:USC Ophthalmology Residency Program Ranked in Top 10 by Doximity 3Health News:Lalonde Gordon’s Recipe Brings Home the Gold 2Health News:Lalonde Gordon’s Recipe Brings Home the Gold 3Health News:FiltersFast.com Wows with a Long Labor Day Weekend Shipping Offer 2
... patients who are infected with Clostridium difficile -- ... will lengthen their stay by about six days on average, ... to controlling the spread of the bacterial infection known as ... 5 in the journal CMAJ , researchers analyzed information ...
... M.D., M.S., assistant professor of medicine at the Indiana ... winner of the mHealth Alliance and Rockefeller Foundation,s Top ... goal is to recognize individuals who have used mobile ... outcomes particularly in the most remote areas of the ...
... , MONDAY, Dec. 5 (HealthDay News) -- Teenagers ... photosensitivity, or light sensitivity, researchers say. The combination ... such as flapping their hands in front of their ... Although photosensitivity occurs in up to 14 percent ...
... -- Children who suffer head trauma can experience headaches months after ... a new study finds. The researchers also found that the ... brain injury (TBI) than after a moderate or severe one. ... , included children aged 5 to 17 who were hospitalized ...
... By Alan Mozes HealthDay Reporter , SUNDAY, ... appear to face an increased risk for seizures while watching ... results did reveal that about one in five of these ... television, including nausea, headaches and dizziness. "Normal people have ...
... obese volunteers participating in a 12-week dietary weight-loss ... higher resting nerve activity compared to weight-loss resistant ... The Endocrine Society,s Journal of Clinical Endocrinology ... system is widely distributed throughout the body and ...
Cached Medicine News:Health News:Common Hospital Infection Lengthens Patient Stays 2Health News:Regenstrief investigator a winner of Top 11 in 2011 Innovator Challenge 2Health News:Girls More Prone Than Boys to Headaches After Head Injury 2Health News:3-D TV Doesn't Raise Seizure Risk for Kids With Epilepsy: Study 2Health News:3-D TV Doesn't Raise Seizure Risk for Kids With Epilepsy: Study 3Health News:Nervous system activity may predict successful weight loss 2
These grasping forceps are for fixation of the Fallopian tubes and feature a U-spring handle....
The Optima III 45 cm line of laparoscopic hand instruments is ideal for operative laparoscopic/endoscopic procedures or when a longer instrument is needed....
The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations....
The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations....
Medicine Products: